ACTRN12623000087651尚未招募未知
A Randomised Controlled Crossover Trial to Evaluate the Effect of Two Prolonged Fasting Protocols on Autophagy in Healthy Individuals
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1.Disease status/ or disease group for study: healthy, without disability that may impede cycling exercise.
- •2.Sex: male and female
- •3.Age range: 18-70 years old
- •4.BMI range: 20-40kg/m2
- •5.Basic written and spoken English language proficiency needed for the completion of the questionnaires.
- •6.Willing and able to undergo all study evaluations and adhere to exercise and fasting interventions.
排除标准
- •1.Participants that are pregnant, breastfeeding or of childbearing potential who are not willing to avoid becoming pregnant during the study.
- •2.History of chronic disease processes that according to the investigators could interfere with ability to undergo exercise tests fasting or may affect the interpretation of results.
- •3.People with comorbidities such as (but not limited to) hypertension, diabetes, diagnosed cardiovascular disease
- •4.History of supplement and medication use that may affect the interpretation of results.
- •5.Health condition dietary requirements or life situation that would interfere with study participation and compliance.
- •6.Unintentional weight loss (>10% body weight) over the past 5 years, smoking, psychiatric or behavioural problems (history of drug and alcohol abuse, eating disorder).
- •7.Inability to perform cycling exercise: incremental peak power test during the baseline assessment visit, or the 90-minute glycogen-depleting exercise at the start of the fasting intervention.
- •8.People judged at the investigator’s discretion as being unsuitable to participate.
研究者
相似试验
进行中（未招募）
1 期
Ambulatory Oxygen in Fibrotic Lung DiseaseFibrotic Lung Diseases (FLDs) are chronic and progressive conditions resulting in substantial morbidity and mortality. The cardinal symptom of all fibrotic Interstitial Lung Diseases (ILDs) is shortness of breath. Although initially present only on strenuous activities, this unfortunately progresses until even routine activities of daily living become severely limited. This has a devastating impact on Quality of Life (QOL).MedDRA version: 16.1Level: PTClassification code 10022611Term: Interstitial lung diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-004355-20-GBRoyal Brompton and Harefield NHS Foundation Trust
暂停
不适用
Myopia Progression and Orthokeratology Lens WearProgressing mild late-onset myopiaEye - Diseases / disorders of the eyeACTRN12606000054516Dr Helen Owens, Senior Lecturer, Department of Optometry, University of Auckland50
尚未招募
3 期
A trial to evaluate the effect of obturator on oral health related quality of life made using traditional and digital technique.CTRI/2024/03/063962Dr Bhavita Wadhwa
尚未招募
4 期
The crossover randomized controlled clinical trial with Alirocumab and Evolocumab:CROSS ALIVE StudyThe crossover randomized controlled clinical trial with Alirocumab and Evolocumab:CROSS ALIVE StudyJPRN-UMIN000040727Saitama Medical University Dept. of Endocrinology and Diabetology20
已完成
不适用
VEgetableS for vaScular hEaLth: The VESSEL StudyBlood pressureGlycemic controlInflammationOxidative stressArterial stiffnessCardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - Normal metabolism and endocrine development and functionInflammatory and Immune System - Normal development and function of the immune systemACTRN12619001294145Edith Cowan University21